CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 51, 2012, Pages

  Overdevest, Jonathan B ^a   Knubel, Kristina H ^b   Duex, Jason E ^b   Thomas, Shibu ^a   Nitz, Matthew D ^a   Harding, Michael A ^a   Smith, Steven C ^a   Frierson, Henry F ^a   Conaway, Mark ^c   Theodorescu, Dan ^b,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Carcinogenesis; Genetically engineered mice

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; CD24 ANTIGEN; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER PROGNOSIS; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; METASTATIC UROTHELIAL BLADDER CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UROTHELIAL BLADDER CANCER; XENOGRAFT;

ANDROGENS; ANIMALS; ANTIGENS, CD24; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; RECEPTORS, ANDROGEN; SEX FACTORS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

MUS;

EID: 84871372488     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113960109     Document Type: Article

References (47)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300.
2. Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A (2003) Quality of life aspects of bladder cancer: A review of the literature. Qual Life Res 12:675-688.
3. Wu X-R (2005) Urothelial tumorigenesis: A tale of divergent pathways. Nat Rev Cancer 5:713-725.
4. Smith SC, et al. (2006) The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 66:1917-1922.
5. Overdevest JB, et al. (2011) CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization. Cancer Res 71:3802-3811.
6. Kay R, Rosten PM, Humphries RK (1991) CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J Immunol 147:1412-1416.
7. Kristiansen G, Sammar M, Altevogt P (2004) Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35:255-262.
8. Lee J-H, Kim S-H, Lee E-S, Kim Y-S (2009) CD24 overexpression in cancer development and progression: A meta-analysis. Oncol Rep 22:1149-1156.
9. Sagiv E, Arber N (2008) The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: From research to therapy. Expert Rev Gastroenterol Hepatol 2:125-133.
10. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70.
11. Mierke CT, Bretz N, Altevogt P (2011) Contractile forces contribute to increased glycosylphosphatidylinositol-anchored receptor CD24-facilitated cancer cell invasion. J Biol Chem 286:34858-34871.
12. Baumann P, et al. (2005) CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 65:10783-10793.
13. Li O, Zheng P, Liu Y (2004) CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host. J Exp Med 200:1083-1089.
14. Nielsen PJ, et al. (1997) Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood 89:1058-1067.
15. Wenger RH, et al. (1995) B-cell maturation in chimaeric mice deficient for the heat stable antigen (HSA/mouse CD24). Transgenic Res 4:173-183.
16. Madeb R, Messing EM (2004) Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 22:86- 92.
17. Druckrey H, et al. (1964) Selektive Erzeugung Von Blasenkrebs an Ratten Durch Dibutyl- und N-Butyl-N-Butanol(4)-Nitrosamin [Selective induction of bladder cancer in rats by dibutyl- and N-butyl-N-butanol(4)-]. Z Krebsforsch 66:280-290 [in German].
18. Bertram JS, Craig AW (1970) Induction of bladder tumours in mice with dibutylnitrosamine. Br J Cancer 24:352-359.
19. Ohtani M, et al. (1986) Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Res 46:2001-2004.
20. Williams PD, Lee JK, Theodorescu D (2008) Molecular credentialing of rodent bladder carcinogenesis models. Neoplasia 10:838-846.
21. Bertram JS, Craig AW (1972) Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur J Cancer 8:587-594.
22. Hartge P, et al. (1990) Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 82:1636-1640.
23. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306:737-745.
24. Hemelt M, Yamamoto H, Cheng KK, Zeegers MPA (2009) The effect of smoking on the male excess of bladder cancer: A meta-analysis and geographical analyses. Int J Cancer 124:412-419.
25. Miyamoto H, et al. (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99:558-568.
26. Lim SC, Oh SH (2005) The role of CD24 in various human epithelial neoplasias. Pathol Res Pract 201:479-486.
27. Boorjian SA, et al. (2009) Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Endocr Relat Cancer 16:123-137.
28. Kauffman EC, et al. (2011) Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog 50:931-944.
29. Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS (2006) Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cancer Res 66:10613-10620.
30. Sagiv E, et al. (2006) CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 131:630-639.
31. Senner V, et al. (1999) CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 58:795-802.
32. Baffa R, et al. (2008) Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. Carcinogenesis 29:846-848.
33. Friederichs J, et al. (2000) The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 60:6714-6722.
34. Matsushita K, et al. (2011) Immunohistochemical biomarkers for bladder cancer prognosis. Int J Urol 18:616-629.
35. Mir C, et al. (2011) Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: A large multiinstitutional study. BJU Int 108:24-30.
36. Waliszewski P, Waliszewska MK, Hemstreet GP, 3rd, Hurst RE (1997) Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines. Urol Oncol 3:141-147.
37. Sagiv E, et al. (2008) Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res 68:2803-2812.
38. Wirth M, et al. (2007) Bicalutamide (Casodex) 150 mg plus standard care in early nonmetastatic prostate cancer: Results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up. Prostate Cancer Prostatic Dis 10:87-93.
39. Steeg PS, Theodorescu D (2008) Metastasis: A therapeutic target for cancer. Nat Clin Pract Oncol 5:206-219.
40. Welte K, et al. (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82:1526-1530.
41. Gioeli D, et al. (2006) Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol Endocrinol 20:503-515.
42. Shulewitz M, et al. (2006) Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene 25:4361-4369.
43. Wang L, et al. (2007) A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet 3:e49.
44. Thomas S, et al. (2012) CD24 is an effector of HIF-1 driven primary tumor growth and metastasis. Cancer Res 72:5600-5612.
45. Bigler D, et al. (2003) Gene profiling and promoter reporter assays: Novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action. Oncogene 22:1261-1272.
46. Dart DA, Brooke GN, Sita-Lumsden A, Waxman J, Bevan CL (2011) Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens. Oncogene, 10.1038/onc.2011.591.
47. Agresti A (2002) Categorical Data Analysis (Wiley, New York), 2nd Ed.